News & Events:SEM

  According to Benzinga Pro, during Q2, Select Medical Holdings earned $66.26 million, a 18.48% increase from the preceding quarter. Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business.

  Friday marks the last chance for investors to receive the next dividend payout from Select Medical Hldgs. The company announced on Tuesday that it would pay shareholders a quarterly dividend of 12.5 per share. In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date--in this case, Monday.

Select Medical Holdings Corp (SEM): * ORATION ANNOUNCES RESULTS FOR ITS SECOND QUARTER ENDED JUNE 30, 2022 AND CASH DIVIDEND. * Q2 EARNINGS PER SHARE $0.43. * SEES FY REVENUE $6.25 BILLION TO $6.4 BILLION. * FOR Q2 ENDED JUNE 30, 2022, REVENUE INCREASED 1.3% TO $1,584.7 MILLION, COMPARED TO $1,564.0 MILLION FOR SAME QUARTER, PRIOR YEAR.

Select Medical Hldgs reported its Q2 earnings results on Thursday, August 4, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Select Medical Hldgs missed estimated earnings by 21.82%, reporting an EPS of $0.43 versus an estimate of $0.55. Revenue was up $21.00 million from the same period last year.

MECHANICSBURG, Pa., Aug. 4, 2022 Select Medical Holdings Corporation (SEM) today announced results for its second quarter ended June 30, 2022, and the declaration of a cash dividend. For the second quarter ended June 30, 2022, revenue increased 1.3% to $1,584.7 million, compared to $1,564.0 million for the same quarter, prior year.

  ** Toyota Motor is projected to report earnings for its first quarter. ** Myriad Genetics is expected to report quarterly earnings at $0.01 per share on revenue of $171.00 million. ** Karyopharm Therapeutics is expected to report quarterly loss at $0.63 per share on revenue of $35.59 million.

  ** Toyota Motor is projected to report earnings for its first quarter. ** Myriad Genetics is expected to report quarterly earnings at $0.01 per share on revenue of $171.00 million. ** Karyopharm Therapeutics is expected to report quarterly loss at $0.63 per share on revenue of $35.59 million.

MECHANICSBURG, Pa., July 26, 2022  Select Medical (SEM) today announced four of its inpatient rehabilitation hospitals have been recognized by U.S. News & World Report as Best Hospitals for rehabilitation in the country.

MECHANICSBURG, Pa., July 26, 2022  Select Medical Holdings Corporation (SEM), will release the financial results for its second quarter ended June 30, 2022 on Thursday, August 4, 2022 after the market closes. Select Medical (SEM) will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 5, 2022, at 9:00am ET.

MECHANICSBURG, Pa. and FALLS CHURCH, Va., June 23, 2022 Select Medical Corporation and Inova Health System today announced a joint venture to own and operate the first critical illness recovery hospital in Northern Virginia.  The 32-bed specialty hospital will open in the first half of 2023 and be located within Inova Mount Vernon Hospital.

MECHANICSBURG, Pa. and VENICE, Fla. "We look forward to partnering with ShorePoint Health Venice to address the growing need for specialty care among high acuity patients in Venice and surrounding communities," said Tom Mullin, executive vice president of hospital operations at Select Medical.

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Co-Diagnostics's earnings per share for Q1 sits at $0.34, whereas in Q4, they were at 0.25. Fonar has reported Q3 earnings per share at $0.32, which has decreased by 43.86% compared to Q2, which was 0.57. Select Medical Holdings looks to be undervalued.

Within the last quarter, Select Medical Holdings has observed the following analyst ratings: These 4 analysts have an average price target of $33.25 versus the current price of Select Medical Holdings at $24.34, implying upside. Below is a summary of how these 4 analysts rated Select Medical Holdings over the past 3 months.

Tuesday marks the last chance for investors to receive the next dividend payout from Select Medical Holdings. The company announced on Thursday that it would pay shareholders a quarterly dividend of $0.125 per share. In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday.

  ** Mirum Pharmaceuticals is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. ** Bluegreen Vacations is estimated to report quarterly earnings at $0.53 per share on revenue of $181.17 million. ** Selecta Biosciences is expected to report quarterly loss at $0.11 per share on revenue of $13.12 million.

Analysts have provided the following ratings for Select Medical Holdings within the last quarter: In the last 3 months, 4 analysts have offered 12-month price targets for Select Medical Holdings. Below is a summary of how these 4 analysts rated Select Medical Holdings over the past 3 months.

Select Medical Holdings has observed the following analyst ratings within the last quarter: These 4 analysts have an average price target of $38.0 versus the current price of Select Medical Holdings at $24.28, implying upside. Below is a summary of how these 4 analysts rated Select Medical Holdings over the past 3 months.